Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr 30;9(1):2-7.
eCollection 2014.

Onychomycosis nailed

Affiliations
Review

Onychomycosis nailed

M Leelavathi et al. Malays Fam Physician. .

Abstract

Fungal infection of the nail is a common condition that causes much concern because of its disfiguring appearance. Although specific treatment is available for this condition, treatment outcome is variable and persistent nail dystrophy post-treatment may cause distress to both the patient and the physician. This article describes the current available treatment options for onychomycosis, management approach and the expected treatment outcome to enhance primary care physicians' confidence in managing this condition. Oral antifungal agents such as terbinafine and itraconazole are good treatment options for onychomycosis. Combination therapy using oral antifungal agents with topical lacquer preparations may provide added benefits. Evaluation of patient's expectations, providing information on treatment outcome, clinical cure and recurrence rates are essential in the management of onychomycosis. This article is intended to guide primary care physicians to achieve realistic treatment goals and for a satisfactory experience in the overall management of this challenging condition.

Keywords: antifungal agents; itraconazole; onychomycosis.

PubMed Disclaimer

References

    1. Mügge C, Haustein UF, Nenoff P. Causative agents of onychomycosis–a retrospective study. J Dtsch Dermatol Ges. 2006;10(3):218–28. - PubMed
    1. Botek G. Fungal nail infection: Assessing the new treatment options. Cleve Clin J Med. 2003;70(2):110–4. - PubMed
    1. Tosti A, Hay R, Arenas-Guzmán R. Patients at risk of onychomycosis–risk factor identification and active prevention. J Eur Acad Dermatol Venereol. 2005;19(Suppl 1):13–6. - PubMed
    1. Scher RK, Tavakkol A, Sigurgeirsson B. et al. Onychomycosis: Diagnosis and definition of cure. J Am Acad Dermatol. 2007;56(6):939–44. - PubMed
    1. Leelavathi M, Tzar MN. Nail sampling technique and its interpretation. Malays Fam Physician. 2011;6:58–59. - PMC - PubMed

LinkOut - more resources